Oppenheimer Asset Management Inc. Has $755,000 Stock Position in Masimo Co. (NASDAQ:MASI)

Oppenheimer Asset Management Inc. lifted its stake in Masimo Co. (NASDAQ:MASI) by 27.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,568 shares of the medical equipment provider’s stock after acquiring an additional 984 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Masimo were worth $755,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Oregon Public Employees Retirement Fund increased its position in shares of Masimo by 1.3% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 9,079 shares of the medical equipment provider’s stock valued at $1,501,000 after acquiring an additional 113 shares during the last quarter. Sigma Planning Corp increased its position in shares of Masimo by 21.7% in the fourth quarter. Sigma Planning Corp now owns 3,365 shares of the medical equipment provider’s stock valued at $556,000 after acquiring an additional 600 shares during the last quarter. Navellier & Associates Inc. acquired a new stake in shares of Masimo in the fourth quarter valued at about $1,043,000. Private Advisor Group LLC increased its position in shares of Masimo by 2.5% in the fourth quarter. Private Advisor Group LLC now owns 4,260 shares of the medical equipment provider’s stock valued at $704,000 after acquiring an additional 105 shares during the last quarter. Finally, Cardinal Capital Management increased its position in shares of Masimo by 1.1% in the fourth quarter. Cardinal Capital Management now owns 18,720 shares of the medical equipment provider’s stock valued at $3,094,000 after acquiring an additional 203 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Trading Down 3.8 %

Shares of NASDAQ:MASI opened at $183.46 on Wednesday. Masimo Co. has a 12-month low of $101.61 and a 12-month high of $194.88. The stock has a market cap of $9.90 billion, a PE ratio of 126.52 and a beta of 1.02. The business has a 50 day moving average of $174.43 and a 200-day moving average of $155.05. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.38. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The company had revenue of $600.70 million during the quarter, compared to analysts’ expectations of $593.35 million. As a group, equities research analysts forecast that Masimo Co. will post 4.1 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts recently issued reports on MASI shares. Stifel Nicolaus reaffirmed a “buy” rating and issued a $190.00 target price (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Piper Sandler lifted their price target on Masimo from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Raymond James lifted their price target on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a report on Friday, December 27th. Wells Fargo & Company lifted their price target on Masimo from $193.00 to $205.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a report on Wednesday, February 26th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Masimo has an average rating of “Moderate Buy” and a consensus price target of $194.80.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.